📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo. (2024)

First Author: Bialy D

Attributed to: Understanding animal health threats from emerging H5 high pathogenicity avian influenza viruses funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.virol.2023.109954

PubMed Identifier: 38086284

Publication URI: http://europepmc.org/abstract/MED/38086284

Type: Journal Article/Review

Volume: 590

Parent Publication: Virology

ISSN: 0042-6822